Diagnosis, treatment, and long-term management of Kawasaki disease

scientific article (publication date: 26 October 2004)

Diagnosis, treatment, and long-term management of Kawasaki disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.0000145143.19711.78
P3181OpenCitations bibliographic resource ID1212743
P698PubMed publication ID15505111

P50authorJane W. NewburgerQ47173730
P2093author name stringJane C Burns
Larry M Baddour
Ann F Bolger
Stanford T Shulman
Kathryn A Taubert
Michael A Gerber
Robert S Baltimore
Patricia Ferrieri
Donald A Falace
Masato Takahashi
Walter R Wilson
Michael H Gewitz
Lloyd Y Tani
Matthew E Levison
Thomas J Pallasch
P433issue17
P407language of work or nameEnglishQ1860
P921main subjectKawasaki diseaseQ265936
cardiovascular diseaseQ389735
rheumatic feverQ753904
P304page(s)2747-71
P577publication date2004-10-26
P1433published inCirculationQ578091
P1476titleDiagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
P478volume110

Reverse relations

cites work (P2860)
Q36329296A 15-year review of children with Kawasaki's Syndrome having general anesthesia or deep sedation
Q35628241A 19 year old with Fever, rash, and conjunctivitis: a connection with the heart
Q47344620A 21-Month-Old Male With Refusal to Walk, Rash, and Weight Loss
Q80530967A 21-year-old male with reduced left ventricular function
Q52983124A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease?
Q36668752A Case of Atypical Kawasaki Disease With Myositis
Q41168340A Case of Kawasaki Disease With Concomitant Leptospirosis
Q40194976A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment
Q41380014A Child With Kawasaki Disease and Yersinia enterocolitica Infection: A Closer Look at Pathogenesis
Q39655163A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses
Q48277378A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease
Q89534232A Comprehensive Update on Kawasaki Disease Vasculitis and Myocarditis
Q43793777A Multicenter Study of Intravenous Immunoglobulin Non-response in Kawasaki Disease
Q92542275A New Scoring System for Prediction of Intravenous Immunoglobulin Resistance of Kawasaki Disease in Infants Under 1-Year Old
Q58765263A case of Henoch-Schonlein Purpura with dilated coronary arteries
Q55005085A case of Kawasaki disease masked by pustular type psoriasiform eruptions.
Q40061229A case of atypical Kawasaki disease with giant coronary artery aneurysm containing thrombus
Q41105109A case of early development of giant coronary artery aneurysms after drug-eluting stents implantation: An unpredictable menace
Q55057339A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.
Q34005103A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis
Q38601519A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.
Q29417090A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease
Q38846437A male infant had subdural effusion and paroxysmal supraventricular tachycardia during the febrile episode of Kawasaki disease: a case report and literature review
Q35772471A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease
Q37152274A non-discrete method for computation of residence time in fluid mechanics simulations
Q34874251A replication study for association of ITPKC and CASP3 two-locus analysis in IVIG unresponsiveness and coronary artery lesion in Kawasaki disease
Q34498652A study of cardiovascular miRNA biomarkers for Kawasaki disease.
Q30713533A systematic review of validated methods for identifying Kawasaki disease using administrative or claims data
Q58604070ABCC4 Variants Modify Susceptibility to Kawasaki Disease in a Southern Chinese Population
Q92184027Aberrant expression of serum circANRIL and hsa_circ_0123996 in children with Kawasaki disease
Q40043358Acetylsalicylic acid for children with Kawasaki disease
Q39085593Acquired and congenital coronary artery abnormalities
Q38042869Acquired coronary disease in children: the role of multimodality imaging
Q33276712Activated myeloid dendritic cells accumulate and co-localize with CD3+ T cells in coronary artery lesions in patients with Kawasaki disease
Q24682484Acute Kawasaki disease: not just for kids
Q99402680Acute Myocardial Infarction in a 17-year-old High-school Girl
Q54102172Acute kidney injury occurs only rarely in patients with Kawasaki disease.
Q91865976Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease
Q35495033Adult Kawasaki disease in a European patient: a case report and review of the literature
Q45341752Adult Kawasaki-like syndrome with eosinophilia and tenosynovitis in a patient with human immunodeficiency virus infection.
Q38134469Advances in noninvasive imaging in pediatric cardiology
Q53422735Afebrile Kawasaki disease with coronary artery dilatation.
Q33946142Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease
Q98944934Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease
Q37738895Ambient Air Pollutant Exposures and Hospitalization for Kawasaki Disease in Taiwan: A Case-Crossover Study (2000-2010).
Q61806917An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease
Q37798809An Overview of Surgery Options for Congenital Coronary Artery Anomalies
Q40281545An atypical presentation of Kawasaki disease: a 10-year-old boy with acute exudative tonsillitis and bilateral cervical lymphadenitis
Q34486951An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study
Q80639955An exercise tissue Doppler and strain rate imaging study of diastolic myocardial dysfunction after Kawasaki syndrome in childhood
Q98613608Analysis of Circular RNAs in the Coronary Arteries of Patients with Kawasaki Disease
Q41451230Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis
Q47230629Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients
Q39247857Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
Q42736402Aneurysm of the Left Coronary Artery in Postoperative Bland-White-Garland Syndrome
Q53699543Aneurysmal coronary artery disease: An overview.
Q91905915Answer to Picture Quiz
Q54511046Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells.
Q40036899Anti-platelet agents in pediatric cardiac practice
Q97526980Antibodies and Immunity During Kawasaki Disease
Q47287596Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays.
Q35752608Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Q38169556Appendicitis as the presenting manifestation of Kawasaki disease
Q48272278Application of 2- and 3-Dimensional Sonography Using the Virtual Organ Computer-Aided Analysis Technique to Measure the Hippocampal Formation and Its Correlation With Corrected Gestational Age in Neonates
Q30446491Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease
Q87206709Ascending Aorta Elastography After Kawasaki Disease Compared to Systemic Hypertension
Q38760442Aspiration thrombectomy and intracoronary tirofiban via GuideLiner® catheter for a thrombosed aneurysmal vessel
Q38176141Aspirin for cardioprotection and strategies to improve patient adherence
Q90273129Assessing left ventricular systolic function in children with a history of Kawasaki disease
Q40305032Assessment of risk factors for Korean children with Kawasaki disease
Q53154505Assessment of the relationship between coronary artery ectasia and erectile function score.
Q37349659Associated symptoms in the ten days before diagnosis of Kawasaki disease
Q24620972Associated symptoms of kawasaki disease
Q50352459Association Between Atypical/Incomplete Kawasaki Disease and Sensorineural Hearing Loss: A Case Report
Q33628015Association between Kawasaki disease and autism: a population-based study in Taiwan
Q91638700Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients
Q92030421Association between maternal age and outcomes in Kawasaki disease patients
Q47957321Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study
Q24627845Association of Kawasaki disease with tropospheric wind patterns
Q37232037Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease
Q92825438Association of the IL16 Asn1147Lys polymorphism with intravenous immunoglobulin resistance in Kawasaki disease
Q35915520Association of the resistin gene promoter region polymorphism with Kawasaki disease in Chinese children
Q49270156Atypical Kawasaki Disease Presenting with Hemiparesis and Aphasia: A Case Report
Q43974058Atypical Kawasaki disease
Q82674134Atypical Kawasaki disease--a clinical challenge
Q46615289Atypical and incomplete Kawasaki disease
Q58809663Authors' response to ‘Aspirin dose for treatment of Kawasaki disease’
Q53080610Autoimmune sclerosing cholangitis: An atypical association with kawasaki disease.
Q36445566Axillary, Oral and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease
Q40111745Bacillus Calmette-Guérin reactivation as a sign of incomplete Kawasaki disease
Q64099353Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study
Q38716455Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes
Q50022881C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease
Q58914810CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population
Q46401492CD8+ T Cells Contribute to the Development of Coronary Arteritis in the Lactobacillus casei Cell Wall Extract-Induced Murine Model of Kawasaki Disease
Q87453680CD84 is markedly up-regulated in Kawasaki disease arteriopathy
Q36499266CMR in inflammatory vasculitis
Q98578687COVID-19 and multisystem inflammatory syndrome in children and adolescents
Q35360944CT analysis of retropharyngeal abnormality in Kawasaki disease
Q36731339Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease.
Q34300909Calcium scoring in patients with a history of Kawasaki disease
Q26829091Can Coronary Artery Involvement in Kawasaki Disease be Predicted?
Q38071996Can a systems biology approach unlock the mysteries of Kawasaki disease?
Q38517828Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Q84967206Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction
Q40164908Cardiac Complications in 38 Cases of Kawasaki Disease with Coronary Artery Aneurysm Diagnosed by Echocardiography
Q36365849Cardiac involvement in Kawasaki disease in Pakistani children
Q35658781Cardiovascular biomarkers in acute Kawasaki disease
Q40398208Cardiovascular complications associated with chronic active Epstein-Barr virus infection
Q36307967Cardiovascular imaging in children and adults following Kawasaki disease
Q39654279Cardiovascular involvement in Kawaski Disease
Q79233367Cardiovascular risk factors in adolescents
Q36209060Cardiovascular status after Kawasaki disease in the UK.
Q40185952Case 2: A three-year-old boy with fever and neck pain
Q40471329Case 2: fever, rash and pulmonary involvement. Diagnosis: Kawasaki disease.
Q48286968Catheter-based anatomic and functional assessment of coronary arteries in anomalous aortic origin of a coronary artery, myocardial bridges and Kawasaki disease
Q52983514Cervical ultrasound and computed tomography of Kawasaki disease: Comparison with lymphadenitis.
Q26827088Challenges and priorities for research: a report from the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH) Working Group on thrombosis in pediatric cardiology and congenital heart disease
Q91496816Changes in and significance of platelet function and parameters in Kawasaki disease
Q40323125Characteristics of Kawasaki disease in older children
Q57492609Characterization of coronary artery pathological formations from OCT imaging using deep learning
Q28219158Chronic granulomatous disease associated with atypical Kawasaki disease
Q53211466Chronic total occlusion by stent fracture in Kawasaki disease: is recanalisation possible?
Q39534720Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study
Q47804715Clinical Manifestations of Kawasaki Disease Shock Syndrome
Q90694982Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study
Q40371701Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey
Q34628819Clinical and epidemiological characteristics of kawasaki disease.
Q37626123Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.
Q58333188Clinical features of acute kidney injury in patients with Kawasaki disease
Q45204723Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.
Q37239530Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities
Q50784170Clinical spectrum of incomplete Kawasaki disease in Thailand.
Q35609014Clinical use of aspirin in treatment and prevention of cardiovascular disease
Q33619503Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children
Q42922418Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease.
Q53440355Coding single-nucleotide polymorphisms of interleukin-1 gene cluster are not associated with Kawasaki disease in the Korean population.
Q35144681Common carotid artery intima-media thickness is useful for diagnosis of the acute stage of Kawasaki disease
Q40189017Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease
Q33424419Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin
Q40304052Complete and incomplete Kawasaki disease: two sides of the same coin
Q45279216Comprehensive evaluation of a patient with Kawasaki disease and giant coronary aneurysms with cardiac magnetic resonance.
Q34081277Concomitant respiratory viral infections in children with Kawasaki disease.
Q26776097Consortium-Based Genetic Studies of Kawasaki Disease in Korea: Korean Kawasaki Disease Genetics Consortium
Q49873428Controversies in diagnosis and management of Kawasaki disease
Q93028984Coronary Artery Aneurysms and Thrombosis in Kawasaki Disease
Q30234397Coronary Artery Aneurysms: A Review of the Epidemiology, Pathophysiology, Diagnosis, and Treatment
Q39218092Coronary Artery Anomalies: When You Need to Worry
Q56112189Coronary Artery Dilatation in Toxic Shock-Like Syndrome: The Kawasaki Disease Shock Syndrome
Q40732093Coronary Artery Dilatation in Viral Myocarditis Mimics Coronary Artery Findings in Kawasaki Disease
Q42185155Coronary and intracerebral arterial aneurysms in a young adult with acute coronary syndrome
Q83644760Coronary and systemic aneurysms in an infant with Kawasaki disease
Q37776155Coronary aneurysm and silent myocardial infarction in an adolescent secondary to undiagnosed childhood Kawasaki disease.
Q45202431Coronary arterial ectasia in a 2-year-old boy showing two symptoms of Kawasaki disease without manifesting fever
Q43619242Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography
Q33421535Coronary artery aneurysm presenting as a large mass encroaching on the right atrium in an adult patient with untreated Kawasaki disease
Q50057626Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China
Q42132996Coronary artery aneurysms in a 15-year-old boy.
Q38081856Coronary artery aneurysms: case report and review of transcatheter management strategies
Q92717281Coronary artery assessment in Kawasaki disease with dual-source CT angiography to uncover vascular pathology
Q37472060Coronary artery bypass grafting for coronary artery stenosis caused by Kawasaki disease
Q51072500Coronary artery indexed diameter and z score regression equations in healthy Chinese Han children.
Q30458157Coronary artery involvement in pediatric Takayasu's arteritis: Case report and literature review
Q82904473Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan
Q35821679Coronary artery size and origin imaging in children: a comparative study of MRI and trans-thoracic echocardiography
Q35204034Coronary artery stenosis risk and time course in Kawasaki disease patients: experience at a US tertiary pediatric centre
Q38316327Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms
Q48909732Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease.
Q41613086Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease
Q36797800Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease
Q37585123Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature
Q24194653Corticosteroids for the treatment of Kawasaki disease in children
Q36262749Corticosteroids for the treatment of Kawasaki disease in children.
Q26765479Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome
Q37007652Current perspectives on ophthalmic manifestations of childhood rheumatic diseases
Q50482611Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease.
Q42185658DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease
Q92573217Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease
Q61800095Decreased Steroid Hormone Receptor Expression in Kawasaki Disease Before IVIG Treatment
Q42031240Deep feature learning for automatic tissue classification of coronary artery using optical coherence tomography
Q33846481Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome
Q40324862Delayed diagnosis of Kawasaki disease: risk factors and outcome of treatment
Q99565287Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease
Q53721037Development of Kawasaki disease in a patient with PFAPA.
Q38630748Development of an algorithm for the management of cervical lymphadenopathy in children: consensus of the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Society of Pediatric Infectious Diseases and the Italian Society o
Q64960713Diagnosing Incomplete Kawasaki Disease.
Q56880528Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature
Q48315964Diagnosis of Kawasaki disease
Q42557070Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site
Q28191466Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience
Q39160330Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Q36123376Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children
Q34618655Differential expression of miR-145 in children with Kawasaki disease
Q40066217Difficult diagnosis of atypical kawasaki disease in an infant younger than six months: a case report.
Q40312655Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins
Q35118513Distribution and Protective Role of HLAB40 in Iranian Patients with Kawasaki Disease; a Report from Southern Iran
Q37187114Dual antiplatelet therapy with clopidogrel and aspirin
Q88096896Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease
Q30969802Dynamic Changes, Cut-Off Points, Sensitivity, and Specificity of Laboratory Data to Differentiate Macrophage Activation Syndrome from Active Disease.
Q40166091Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance
Q36323370Early Detection of Kawasaki Disease in Infants.
Q41772293Echocardiographic Evaluation of Coronary Abnormalities and Cardiac Function in a Murine Model of Kawasaki Disease Using High-frequency Ultrasound
Q55446513Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
Q40430234Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin
Q92218380Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis
Q92137694Emergence and Characterization of Acute Coronary Syndrome in Adults After Confirmed or Missed History of Kawasaki Disease in Japan: A Japanese Nationwide Survey
Q42857022Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones
Q90240804Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017
Q34112495Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan
Q36949257Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience
Q47636282Epidemiological trends of Kawasaki disease among paediatric patients admitted to the Wendy Fitzwilliam Paediatric Hospital, Trinidad, during 2004-2007.
Q38012529Epidemiology and management of Kawasaki disease
Q39456935Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period
Q37234284Epidemiology of Kawasaki disease in Asia, Europe, and the United States
Q54945663Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease.
Q42010551Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
Q34428807Erythema at BCG Inoculation Site in Kawasaki Disease Patients
Q37129983Establishment of Kawasaki disease database based on metadata standard
Q36513183Ethnic Kawasaki Disease Risk Associated with Blood Mercury and Cadmium in U.S. Children
Q34785741Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance
Q87498901Evaluation of echogenicity of the heart in Kawasaki disease
Q81139189Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease
Q37589256Evidence of Microvascular Changes in the Retina following Kawasaki Disease
Q35569106Evolution of laboratory values in patients with Kawasaki disease
Q41756575Exploring the genes associated with the response to intravenous immunoglobulin in patients with Kawasaki disease using DNA microarray analysis
Q83454274Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease
Q35673684FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.
Q92812905Facial nerve palsy presenting as rare neurological complication of Kawasaki disease: A case report
Q47368744Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.
Q43838083Factors associated with low moderate-to-vigorous physical activity levels in pediatric patients with Kawasaki disease
Q64292449Familial Mediterranean Fever Gene Mutations and Gout as an Auto-Inflammatory Arthropathy
Q34021290Familial occurrence of Kawasaki syndrome in North America
Q34024542Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.
Q40073272Fever and a Morbilliform Rash
Q40058181Fever without a source: evolution of a diagnosis from Kawasaki disease to acute myelogenous leukaemia.
Q80821449First recanalization of a coronary artery chronic total obstruction in an 11-year-old child with Kawasaki disease sequelae using the CROSSER catheter
Q48835164Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification
Q89373826Gastrointestinal involvement in Kawasaki disease: a case report
Q92190882Gene Polymorphism of Aspirin-Induced Urticaria in Children With Kawasaki Disease
Q33883840Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection
Q35855926Gene-Gene Associations with the Susceptibility of Kawasaki Disease and Coronary Artery Lesions
Q36465545Gene-expression patterns reveal underlying biological processes in Kawasaki disease
Q33566136Genetic polymorphisms in Kawasaki disease
Q24624734Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease
Q84416881Genetics insights into the pathogenesis of Kawasaki disease
Q29417017Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease
Q61445186Genome-wide transcriptome analysis to further understand neutrophil activation and lncRNA transcript profiles in Kawasaki disease
Q89458577Giant Thrombotic Right Coronary Aneurysm in an Infant with Undiagnosed Incomplete Kawasaki Disease and Rapidly Progressive Cardiovascular Collapse
Q83176729Giant coronary and systemic aneurysms of Kawasaki disease in an infant
Q53350804Giant coronary aneurysm in adult Kawasaki disease: angiographic, 64-slice coronary MDCT and cardiac MRI appearances.
Q83097313Giant coronary aneurysms caused by Kawasaki disease
Q42737071Giant coronary artery aneurysm following Kawasaki disease: follow-up by various cardiac imaging modalities
Q39676543Giant coronary artery aneurysm with a thrombus secondary to Kawasaki disease
Q45709876Giant coronary artery aneurysms in Kawasaki disease: the cost of a missed diagnosis
Q58543347Giant right coronary artery aneurysm secondary to Kawasaki disease in an infant
Q43239390Giant right coronary artery aneurysm secondary to Kawasaki disease in child: a case report
Q41601611Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm
Q54144614Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).
Q51149871HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
Q38609844Health impact of childhood and adolescent soy consumption
Q22306347Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Q22306345Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association
Q22241921Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association
Q30238784Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association
Q29547236Heart disease and stroke statistics--2011 update: a report from the American Heart Association
Q29547909Heart disease and stroke statistics--2012 update: a report from the American Heart Association
Q35096658Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children.
Q38837772High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease
Q58598815High antistreptolysin O titer is associated with coronary artery lesions in patients with Kawasaki disease
Q28396984High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
Q34641944High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study
Q44734284Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease
Q37459020Hoarseness as a presenting sign in children with Kawasaki disease
Q33924807Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease
Q36326783IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β
Q34047318IL-31 associated with coronary artery lesion formation in Kawasaki disease
Q47108668ITPKC and SLC11A1 Gene Polymorphisms and Gene-Gene Interactions in Korean Patients with Kawasaki Disease.
Q38869612Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis
Q50991494Identification of KCNN2 as a susceptibility locus for coronary artery aneurysms in Kawasaki disease using genome-wide association analysis.
Q57301222Identification of LEF1 as a Susceptibility Locus for Kawasaki Disease in Patients Younger than 6 Months of Age
Q93012659Identification of SAMD9L as a susceptibility locus for intravenous immunoglobulin resistance in Kawasaki disease by genome-wide association analysis
Q53672027Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
Q49188517Identification of differentially expressed microRNAs in acute Kawasaki disease
Q41863276Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease
Q46595474Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease
Q38551736Imaging of systemic vasculitis in childhood
Q36905998Imaging studies in the diagnosis and management of vasculitis
Q55280563Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease.
Q38842992Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity
Q35193974Immunoglobulin Resistance in Kawasaki Disease
Q87258695Importance of evaluation of the right coronary artery by two-dimensional echocardiography in patients after Kawasaki disease: a right parasternal approach
Q43818328Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease
Q35602584Imputation of class I and II HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study
Q36997642Incidence Rate and Epidemiological and Clinical Aspects of Kawasaki Disease in Children of Maghrebi Origin in the Province of Quebec, Canada, Compared to the Country of Origin
Q40235964Incomplete Kawasaki disease associated with complicated Streptococcus pyogenes pneumonia: A case report
Q40271742Incomplete Kawasaki disease followed by systemic onset juvenile idiopathic arthritis- the diagnostic dilemma.
Q40419265Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor
Q38620770Incomplete Kawasaki disease induced by measles in a 6-month-old male infant
Q42414114Incomplete Kawasaki disease: The usefulness of BCG reactivation as a diagnostic tool
Q41935364Incomplete Kawasaki disease: early findings consist of congestive heart failure due to valvular heart disease
Q42706164Incomplete Kawasaki disease: not to be forgotten
Q40389269Incomplete Kawasaki syndrome followed by systemic onset-juvenile idiopathic arthritis mimicking Kawasaki syndrome
Q64882658Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature.
Q28222748Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab
Q43809703Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis
Q43246556Incomplete kawasaki disease in an elderly man.
Q40373887Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report
Q64081934Increase expression of CD177 in Kawasaki disease
Q37166692Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan
Q83576484Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease
Q45161770Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients
Q40216635Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
Q34021198Infliximab treatment for refractory kawasaki disease in korean children.
Q33798966Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease
Q52564165Influence of Latitude on the Prevalence of Kawasaki Disease: A Retrospective Cohort Study from the Taiwan National Health Insurance Database and Review of the Literature.
Q39825109Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease
Q44568677Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease
Q49980459Innate immune responses following Kawasaki disease and toxic shock syndrome.
Q40086687Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease
Q24633011Interleukin-1β is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease
Q36601910Interleukin-21 receptor gene polymorphisms in kawasaki disease
Q91075915Internal iliac artery thrombosis in a 2-month-old infant with incomplete Kawasaki disease
Q35955607Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs
Q33405903Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Q80772612Intravenous pulsed corticosteroid therapy for primary treatment of Kawasaki disease
Q34544046Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease
Q43274889Involvement of tryptophan hydroxylase 2 (TPH2) gene polymorphisms in susceptibility to coronary artery lesions in Korean children with Kawasaki disease
Q47438817Is Kawasaki disease an infectious disorder?
Q36774715Is high-dose aspirin necessary in the acute phase of kawasaki disease?
Q90455679Kawasaki Disease
Q90445229Kawasaki Disease Complicated with Cerebral Vasculitis and Severe Encephalitis
Q41893335Kawasaki Disease Presenting as Acute Intestinal Obstruction
Q89967273Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India
Q34954126Kawasaki Disease in Ghana: Case Reports from Korle Bu Teaching Hospital
Q37458396Kawasaki Disease update
Q89868215Kawasaki Disease: Global Burden and Genetic Background
Q38591900Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective
Q28222919Kawasaki disease
Q91908250Kawasaki disease - A common childhood vasculitis
Q53699546Kawasaki disease among Egyptian children: A case series.
Q38734917Kawasaki disease and cardiovascular risk: a comprehensive review of subclinical vascular changes in the longer term
Q38638912Kawasaki disease and coronary artery aneurysms: from childhood to adulthood
Q64884960Kawasaki disease and familial mediterranean fever gene mutations, is there any link?
Q34632880Kawasaki disease and subsequent risk of allergic diseases: a population-based matched cohort study
Q37243549Kawasaki disease associated with Mycoplasma pneumoniae
Q43184929Kawasaki disease causing giant saccular aneurysms of the coronary arteries: echocardiographic and 64-slice computed tomographic angiographic findings.
Q64247584Kawasaki disease complicating bilateral facial nerve palsy and giant coronary artery aneurysms: A case report
Q28073137Kawasaki disease for dermatologists
Q37953978Kawasaki disease in Jordan: demographics, presentation, and outcome
Q37506277Kawasaki disease in Mongolia: results from 2 nationwide retrospective surveys, 1996-2008.
Q37390888Kawasaki disease in Sicily: clinical description and markers of disease severity.
Q40125408Kawasaki disease in a healthcare provider: an adult case in a paediatric resident
Q35569102Kawasaki disease in monozygotic twins
Q40635875Kawasaki disease incidence at Chandigarh, North India, during 2009-2014.
Q42265896Kawasaki disease resembling acute colitis
Q60920531Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition
Q90028850Kawasaki disease with giant aneurysm of left coronary artery and complete occlusion of right coronary artery
Q34549795Kawasaki disease-specific molecules in the sera are linked to microbe-associated molecular patterns in the biofilms
Q89736529Kawasaki disease: Clinico-laboratory spectrum and outcome in a cohort of children treated at a tertiary care hospital in Islamabad, Pakistan
Q40054079Kawasaki disease: Medical therapies
Q40054066Kawasaki disease: State of the art.
Q38627718Kawasaki disease: a comprehensive review of treatment options.
Q30249349Kawasaki disease: a matter of innate immunity.
Q53162767Kawasaki disease: a rare case of diffuse coronary involvement.
Q30470372Kawasaki disease: a review with emphasis on cardiovascular complications
Q40276542Kawasaki disease: always straight to the heart?
Q36790385Kawasaki disease: an epidemiological study in central Italy
Q38945126Kawasaki disease: etiopathogenesis and novel treatment strategies
Q37000664Kawasaki disease: four case reports of cardiopathy with an institutional and literature review
Q38439648Kawasaki disease: insights into pathogenesis and approaches to treatment
Q95840421Kawasaki disease: pathophysiology and insights from mouse models
Q57795961Kawasaki disease: two case reports from the Aga Khan Hospital, Dar es Salaam-Tanzania
Q87451318Kawasaki disease: unusual clinical manifestations
Q35184950Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas
Q27009431Kidney and urinary tract involvement in kawasaki disease
Q55317014Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome.
Q54545150Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children.
Q37071574Late development of coronary artery abnormalities could be associated with persistence of non-fever symptoms in Kawasaki disease
Q87226167Late symptomatic myocarditis in Kawasaki disease: an unusual manifestation
Q51554654Left ventricular non-compaction revealed by aortic regurgitation due to Kawasaki disease in a boy with LDB3 mutation.
Q34395917Lipoprotein particle concentrations in children and adults following Kawasaki disease
Q53085709Lone aspiration thrombectomy without stenting for a patient with ST-segment elevation myocardial infarction associated with coronary ectasia.
Q41190916Long-Term Prognosis for Patients with Kawasaki Disease Complicated by Large Coronary Aneurysm (diameter ≥6 mm).
Q44215704Long-term evaluation of endothelial function in Kawasaki disease patients
Q45981768Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions.
Q55428714Long-term outcome of coronary artery dilatation in Kawasaki disease.
Q36798211Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease
Q91856923Lymphocyte Hydrogen Sulfide Production Predicts Coronary Artery Lesions in Children with Kawasaki Disease: A Preliminary, Single-Center Study
Q93266106Lymphocyte hydrogen sulfide production predicts intravenous immunoglobulin resistance in children with Kawasaki disease: A preliminary, single-center, case-control study
Q38644813Making a Case for Pediatric Antimicrobial Stewardship Programs
Q91908310Maladie de Kawasaki
Q41493083Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease
Q37465500Management of Kawasaki disease
Q58921960Management of Kawasaki disease: corticosteroids revisited
Q36344968Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease
Q34423714Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease
Q92151642Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
Q33853629Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease.
Q38828840Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
Q90666327MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease
Q92617362MiR-197-3p regulates endothelial cell proliferation and migration by targeting IGF1R and BCL2 in Kawasaki disease
Q57154331MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway
Q88083249Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities
Q41838662Missed Kawasaki disease in childhood presenting as myocardial infarction in adults
Q47282158Molecular basis of coronary artery dilation and aneurysms in patients with Kawasaki disease based on differential protein expression
Q30369509Multimodality Cardiac Imaging in a Patient with Kawasaki Disease and Giant Aneurysms.
Q58079436Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration
Q111911746Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities
Q38405051Mycoplasma Infection as a cause of Persistent Fever after Intravenous Immunoglobulin Treatment of Patients with Kawasaki Disease: Frequency and Clinical Impact
Q40319114Mycoplasma pneumoniae infection in patients with Kawasaki disease
Q64261888Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis
Q53724814Myocardial infarction in a 4-year-old child: role of echocardiography in diagnosis.
Q40253880Myocardial strain and strain rate in Kawasaki disease
Q90544457N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease
Q38719434Natriuretic Peptides in Kawasaki Disease: the Myocardial Perspective
Q43822577Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease
Q40431662Nephromegaly in children with Kawasaki disease: new supporting evidence for diagnosis and its possible mechanism.
Q64075568Neutrophil-to-Lymphocyte Ratio Predicts Intravenous Immunoglobulin-Resistance in Infants Under 12-Months Old With Kawasaki Disease
Q89577552Neutrophil-to-lymphocyte ratio as a biomarker for predicting the intravenous immunoglobulin-resistant Kawasaki disease
Q64987492New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity.
Q33300097Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndrome
Q37983728Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals?
Q37324499Novel Echocardiographic Indices for Assessing the Left Main Coronary Artery in Children With Kawasaki Disease.
Q30984727Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease
Q30541810Novel finding of coronary ectasia in a case of acute rheumatic Fever.
Q30846279Observational study of Interleukin-21 (IL-21) does not distinguish Kawasaki disease from other causes of fever in children
Q34065309Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature
Q40219703Orbital cellulitis presenting as a first sign of incomplete kawasaki disease.
Q90600240Orthostatic and Exercise Effects in Children Years After Kawasaki Disease
Q54482946Orthotopic heart transplant for treatment-resistant cardiomyopathy in Kawasaki syndrome: report of a successful case.
Q64093818Outcomes of Kawasaki Disease Children With Spontaneous Defervescence Within 10 Days
Q40179288Outcomes of Kawasaki Disease: A Single-Center Experience
Q96168428Outcomes of Kawasaki disease with giant coronary aneurysms: a single-centre study in southwest China
Q38546497Overview of Pharmacological Treatment Options for Pediatric Patients with Refractory Kawasaki Disease
Q84049759Paediatric rheumatology: Corticosteroids as primary therapy in Kawasaki disease
Q40314507Parameters to guide retreatment after initial intravenous immunoglobulin therapy in kawasaki disease
Q40140080Patterns of Fever in Children After Primary Treatment for Kawasaki Disease
Q37305538Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady
Q34991282Pediatric cardiac emergencies: Children are not small adults
Q51362339Percutaneous coronary intervention for acute myocardial infarction in a pediatric patient with coronary aneurysm and stenosis due to Kawasaki disease.
Q33958462Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease
Q55381478Perianal skin peeling: An important clinical pointer toward Kawasaki disease.
Q45787083Peribronchovascular haze: a frequently observed finding on chest X-rays in the acute phase of Kawasaki disease
Q35688049Peripheral Endothelial (Dys)Function, Arterial Stiffness and Carotid Intima-Media Thickness in Patients after Kawasaki Disease: A Systematic Review and Meta-Analyses
Q24658305Periungual desquamation in patients with Kawasaki disease
Q35576942Persistent fever in an infant: incomplete Kawasaki disease.
Q60701323Phenotype and coronary outcome in Kawasaki's disease
Q44283481Physical activity recommendations for patients with electrophysiologic and structural congenital heart disease: a survey of Canadian health care providers.
Q36104063Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.
Q84743191Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease
Q33729848Platelet Endothelial Cell Adhesion Molecule-1 Gene Polymorphisms are Associated with Coronary Artery Lesions in the Chronic Stage of Kawasaki Disease.
Q82511806Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis
Q33438988Point-of-care differentiation of Kawasaki disease from other febrile illnesses
Q80729451Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease
Q82100041Polymorphisms of transforming growth factor-β signaling pathway and Kawasaki disease in the Taiwanese population
Q38676515Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores
Q42678825Prediction for Intravenous Immunoglobulin Resistance by Using Weighted Genetic Risk Score Identified From Genome-Wide Association Study in Kawasaki Disease.
Q40073906Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease
Q51594255Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.
Q80079297Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment
Q37634543Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease.
Q40467858Predictive risk factors for coronary artery abnormalities in Kawasaki disease.
Q37713300Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
Q40207614Predictors of coronary artery aneurysms in Kawasaki disease
Q34497863Predictors of coronary artery visualization in Kawasaki disease
Q40080910Predictors of diagnostic accuracy and safe management in difficult diagnostic problems in family medicine
Q38923203Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
Q55365314Pregnancy in Woman with Kawasaki Disease and Multiple Coronary Artery Aneurysms.
Q34145610Pregnancy in women with a history of Kawasaki disease: management and outcomes
Q92424339Prescribing patterns of coronary artery aneurysm in Taiwan
Q36086612Prevalence of Kawasaki disease in young adults with suspected myocardial ischemia
Q39399053Preventing coronary artery lesions in Kawasaki disease
Q50555447Primary percutaneous coronary intervention for acute myocardial infarction due to possible sequelae of Kawasaki disease in young adults: a case series
Q40803261Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Q35819600Profiles of responses of immunological factors to different subtypes of Kawasaki disease
Q36375787Prolonged urticaria and fever in a toddler
Q44581830Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population
Q53699539Pseudo-normalization of a coronary artery aneurysm detected by IVUS.
Q37018368Psoriasiform eruptions during Kawasaki disease (KD): A distinct phenotype
Q54682312Ptosis as a complication of Kawasaki disease.
Q40197710Pulmonary Artery Dilation and Right Ventricular Function in Acute Kawasaki Disease
Q37335438Pyuria associated with acute Kawasaki disease and fever from other causes
Q38764634QT Dispersion and T Wave Peak-to-end Interval Dispersion in Children with Kawasaki Disease
Q36236239Qing Re Liang Xue Decoction Alleviates Hypercoagulability in Kawasaki Disease
Q30394049Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki disease
Q26744310Radiological features of uncommon aneurysms of the cardiovascular system
Q51185384Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada.
Q28217527Re-treatment regimens for acute stage of Kawasaki disease patients who failed to respond to initial intravenous immunoglobulin therapy: analysis from the 17th nationwide survey
Q38575942Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.
Q54961260Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.
Q33765278Recognition of a Kawasaki disease shock syndrome
Q40400914Recognition of kawasaki disease.
Q55020028Recurrent Kawasaki disease: USA and Japan.
Q34513089Recurrent fever syndromes in patients after recovery from Kawasaki syndrome
Q91706456Refractory Kawasaki disease: diagnostic and management challenges
Q40388893Refractory pneumonia and high fever
Q54198415Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.
Q39782962Relationship between gallbladder distension and lipid profiles in kawasaki disease
Q92407238Relationship between ocular involvement and clinical manifestations, laboratory findings, and coronary artery dilatation in Kawasaki disease
Q36854706Resistance to intravenous immunoglobulin in children with Kawasaki disease
Q43202462Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome
Q41552267Retrospective analysis of risk factors associated with Kawasaki disease in China.
Q94547418Reuma.pt/vasculitis - the Portuguese vasculitis registry
Q38993829Review: Found in Translation: International Initiatives Pursuing Interleukin-1 Blockade for Treatment of Acute Kawasaki Disease
Q50041746Review: surgical treatment of giant coronary aneurysms in pediatric patients with Kawasaki disease
Q38948370Revisiting the role of environmental and climate factors on the epidemiology of Kawasaki disease.
Q36426845Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report
Q55154327Risk Factors Related to Coronary Artery Outcome in Kawasaki Disease.
Q90706566Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis
Q40399146Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
Q36854043Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease
Q47589960Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
Q36849601Role of Interleukin-1 Signaling in a Mouse Model of Kawasaki Disease-Associated Abdominal Aortic Aneurysm
Q50071875Role of intravenous immunoglobulin in the treatment of Kawasaki disease
Q40030087Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population
Q38704612ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: an important sequela of Kawasaki disease and a management challenge
Q47104522Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease?
Q36531763Salvianolic Acid B Down-regulates Matrix Metalloproteinase-9 Activity and Expression in Tumor Necrosis Factor-α-induced Human Coronary Artery Endothelial Cells
Q41665077Screening of differentially expressed genes associated with Kawasaki disease by microarray analysis
Q55049526Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight.
Q34994749Seasonality of Kawasaki disease: a global perspective
Q36363661Sensorineural hearing loss in patients with Kawasaki disease
Q90448458Serum IP-10 and IL-17 from Kawasaki disease patients induce calcification-related genes and proteins in human coronary artery smooth muscle cells in vitro
Q34031949Serum brain natriuretic peptide in children with Kawasaki disease
Q42155203Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease.
Q99710925Serum proteins may facilitate the identification of Kawasaki disease and promote in vitro neutrophil infiltration
Q37710599Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease
Q53601864Severe desquamation in Kawasaki disease: Is it somehow protective?
Q40918218Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities?
Q40041622Sex Differences in Pediatric Rheumatology.
Q91228078Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study
Q51500753Shock: an unusual presentation of Kawasaki disease.
Q91909047Significance of Differential Characteristics in Infantile Kawasaki Disease
Q40236353Sociodemographic profile of children with Kawasaki disease in North India
Q53157295Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
Q33851898Spatial and temporal clustering of Kawasaki syndrome cases
Q59792948Spatiotemporal clustering of cases of Kawasaki disease and associated coronary artery aneurysms in Canada
Q40338735Spectrum of kawasaki disease
Q35799392Spontaneous closure of patent ductus arteriosus after an episode of Kawasaki disease: a case report
Q42754568Stent implantation of left main coronary artery stenosis in an infant: Effective long-term treatment?
Q46202051Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study
Q38541112Stress echocardiography in paediatric cardiology
Q40321637Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease
Q36374231Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)
Q38823957Sudden cardiac death from structural heart diseases in adults: imaging findings with cardiovascular computed tomography and magnetic resonance.
Q82205291Syndrome of inappropriate anti‐diuretic hormone in Kawasaki disease
Q35040809Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population
Q64990650Systemic and pulmonary artery aneurysms in incomplete Kawasaki disease.
Q80172901T cell activation profiles in Kawasaki syndrome
Q36323375T-Helper Cytokine Profiles in Patients with Kawasaki Disease
Q56759657TNF-α blockers for the treatment of Kawasaki disease in children
Q36949286The Clinical Profile of Kawasaki Disease in Algerian Children: A Single Institution Experience
Q36004589The Complexities of the Diagnosis and Management of Kawasaki Disease
Q42368365The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?
Q64064159The Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease
Q98290720The Importance of Serum N-Terminal Pro-Brain Natriuretic Peptide and Endogenous Hydrogen Sulfide for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease Patients: Findings From a Tertiary Care Hospital in Karachi, Pakistan
Q35284683The Quality of Practice Committee of the RCPCH
Q39838568The Xi'an Experience of Kawasaki Disease - Lessons Learnt over 5 years
Q49329732The association between oxidative stress and endothelial dysfunction in early childhood patients with Kawasaki disease.
Q89107272The association between the miR-146a rs2910164 C>G polymorphism and Kawasaki disease in a southern Chinese population
Q33639687The clinical profile of Kawasaki disease of children from three Polish centers: a retrospective study
Q42315522The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease
Q54155405The emergence of Kawasaki disease in India and China.
Q38537961The epidemiology of Kawasaki disease: a global update
Q40283224The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.
Q37175810The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease
Q53806066The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis.
Q92236795The radial augmentation index in children with Kawasaki disease without acute coronary artery lesions during the convalescent period
Q51733083The risk of hospitalization for respiratory tract infection (RTI) in children who are treated with high-dose IVIG in Kawasaki Disease: a nationwide population-based matched cohort study.
Q36457051The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease
Q33718942The roles of Ca2+/NFAT signaling genes in Kawasaki disease: single- and multiple-risk genetic variants
Q97528185The rs1051931 G>A Polymorphism in the PLA2G7 Gene Confers Resistance to Immunoglobulin Therapy in Kawasaki Disease in a Southern Chinese Population
Q58801947The rs1625579 T>G polymorphism in the gene confers a risk of early- onset Kawasaki disease in a southern Chinese population
Q64262299The rs4919510 G>C polymorphism confers reduce coronary injury of Kawasaki disease in a Southern Chinese population
Q26750499Therapeutic advances in the treatment of vasculitis
Q39211874Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease
Q46456444Thrombus in a coronary artery aneurysm shortly after warfarin withdrawal
Q38695974Time to focus on outcome assessment tools for childhood vasculitis
Q41216033Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease
Q34088555Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance
Q27025884Treatment of Kawasaki disease by different doses of immunoglobulin: a meta analysis of efficacy and safety
Q35063963Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G
Q98156924Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products
Q51070610Two cases with past Kawasaki disease developing acute myocardial infarction in their thirties, despite being regarded as at low risk for coronary events.
Q43714099Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease
Q40447374Unilateral cervical mass as a main clue raising the diagnostic suspicion of Kawasaki syndrome.
Q39077552Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness
Q40793680Unplanned Repeat Echocardiography with Sedation in Children: Patient Risk Factors
Q64229355Unusual Presentation of Kawasaki Disease in a 13-year-old Saudi Boy
Q28550044Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses
Q36602116Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease
Q36407658Usefulness of Neutrophil to Lymphocyte Ratio in Prediction of Coronary Artery Lesions in Patients with Kawasaki Disease
Q83475021Usefulness of myocardial perfusion imaging with exercise testing in children
Q35466181Usefulness of natriuretic peptide for the diagnosis of Kawasaki disease: a systematic review and meta-analysis.
Q38850359Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes
Q53755859Utility of adenosine stress perfusion CMR to assess paediatric coronary artery disease.
Q97549100Validation of genome-wide associated variants for Kawasaki disease in a Taiwanese case-control sample
Q38011899Variability in delivery of care and echocardiogram surveillance of Kawasaki disease
Q60930481Variation in IL-21-secreting circulating follicular helper T cells in Kawasaki disease
Q40292278Variations in the number of CCL3L1 gene copies and Kawasaki disease in Korean children
Q36181470Various coronary artery complications of Kawasaki disease: Series of 5 cases and review of literature.
Q61452114Vascular imaging findings with high-pitch low-dose dual-source CT in atypical Kawasaki disease
Q38259908Vasculitides and the Complement System: a Comprehensive Review
Q38591612Vasculitis as an adverse event following immunization - Systematic literature review.
Q91741001Vasculitis: A Checklist to Approach and Treatment Update for Dermatologists
Q34074677Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.
Q53831299Verification of risk scores to predict i.v. immunoglobulin resistance in incomplete Kawasaki disease.
Q90013988Very Early Development and Recognition of Coronary Involvement in a Febrile Infant with Typical Signs of Kawasaki Disease
Q53465808Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization.
Q46890541Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease
Q33851902When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood
Q55002256Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease.
Q83819063Woven right and aneurysmatic left coronary artery associated with Kawasaki disease in a 9-month-old patient
Q95511655[Changes in peripheral blood T helper 9 cells and interleukin-9 in children in the acute stage of Kawasaki disease]
Q81532252[Corticoid use in the treatment of Kawasaki disease]
Q81468921[Severe neonatal Kawasaki disease]
Q95516467[Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease]
Q38383813miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
Q41379432L’acide acétylsalicylique pour les enfants atteints de la maladie de Kawasaki

Search more.